Exblifep

Active Ingredient(s): Cefepime Hydrochloride + Enmetazobactam
FDA Approved: * February 22, 2024
Pharm Company: * ALLECRA THERAPS
Category: Antibiotics
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Exblifep Intravenous Injection, Powder, for Solution
NDC: 83289-101
Labeler:
Allecra Therapeutics Sas